Exodus Point Capital Management, LP Artivion, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Artivion, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 37,650 shares of AORT stock, worth $1.09 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,650
Previous 394,228
90.45%
Holding current value
$1.09 Million
Previous $10.1 Million
90.09%
% of portfolio
0.01%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding AORT
# of Institutions
174Shares Held
35.8MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$192 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$81.3 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$81 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$79.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$71.1 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.17B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...